Skip to main content
OpenTrials
Completed

NCT Number: NCT00296738

123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation

Myocardial scintigraphy with 123I-MIBG allows for visual and semi-quantitative assessment of sympathetic cardiac innervation using the hear to mediastinum ratio (HMR). Impaired cardiac MIBG clearance may occur in patients with congestive heart failure (CHF). The purpose of present study was to develop and validate a quantitative index for the assessment of cardiac MIBG uptake kinetics using SPECT/CT for diagnosis of CHF

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Diseases Cardiovascular Diseases Heart Diseases

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Rambam Medical Center

Haifa, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age>40

Exclusion criteria

  • none

Treatment and study plan

SPECT/CT

Device

GE INFINIA HAWKEYE

Primary outcomes

  1. The impact of the imaging modality on patient management

    Time frame: 2 years

Secondary outcomes

  1. The impact on patient management

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Rambam Health Care Campus

Other

Registry information

Official study title

Quantitative 123I-MIBG SPECT/CT Assessment of Cardiac Sympathetic Innervation

Important dates

Study start
2007
Primary completion
2009
Study completion
2010
First posted
Feb 27, 2006
Registry last updated
Aug 18, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.